699
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Medical toxicologists’ practice patterns regarding drug-induced QT prolongation in overdose patients: A survey in the United States of America, Europe, and Asia Pacific region

, &
Pages 204-209 | Received 17 Nov 2014, Accepted 26 Jan 2015, Published online: 23 Feb 2015

References

  • Kao LW, Furbee RB. Drug-induced q-T prolongation. Med Clin North Am 2005; 89:1125–1144.
  • Li EC, Esterly JS, Pohl S, Scott SD, McBride BF. Drug-induced QT-interval prolongation: considerations for clinicians. Pharmacotherapy 2010; 30:684–701.
  • Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American heart association and the American college of cardiology foundation. Circulation 2010; 121:1047–1060.
  • Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/ American heart association task force and the European society of cardiology comittee. Circulation 2006; 114:e385–484.
  • Manini AF, Stimmel B, Vlahov D. Racial susceptibility for QT prolongation in acute drug overdoses. J Electrocardiol 2014; 47:244–250.
  • Letsas KP, Tsikrikas S. Drug-induced proarrhythmia : QT interval prolongation and torsades de pointes. Hospital Chronicles 2011; 6:118–122.
  • Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother 2003; 37:999–1002.
  • Chan A, Isbister GK, Kirkpatrick CMJ, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007; 100:609–615.
  • Isbister GK, Balit CR, Macleod D, Duffull SB. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes. J Clin Psychopharmacol 2010; 30:391–395.
  • American College of Medical Toxicology National Journal Club. Am Coll Med Toxicol 2013. Available at: www.acmt.net. Accessed September 10, 2013.
  • Chiladakis J, Kalogeropoulos A, Zagkli F, Koutsogiannis N, Chouchoulis K, Alexopoulos D. Predicting torsade de pointes in acquired long QT syndrome: Optimal identification of critical QT interval prolongation. Cardiology 2012; 122:3–11.
  • Indik JH, Pearson EC, Fried K, Woosley RL. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval. Heart Rhythm 2006; 3:1003–1007.
  • Ehrlich JR. Choosing tools for QT correction. Heart Rhythm 2006; 3:1008–1009.
  • Chiladakis J, Kalogeropoulos A, Arvanitis P, Koutsogiannis N, Zagli F, Alexopoulos D. Preferred QT correction formula for the assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol 2010; 21:905–913.
  • Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988; 77:392–397.
  • Deal N, Ahn J, Wang E. Focus on: Transcutaneous and transvenous cardiac pacing. ACEP News 2011. Available at: http://www.acep.org/Content.aspx?id = 80813. Accessed June 29, 2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.